Thyroid Genetic Testing
Genetic testing looks for inherited changes that predispose to thyroid disease. It is most established in medullary thyroid cancer and the inherited syndromes that cause it, and in selected cases of congenital hypothyroidism.
Testing is targeted rather than routine — it is offered when the personal or family history suggests an inherited cause.
Last medically reviewed: 15 November 2025
Key points
- Genetic testing is used mainly for medullary thyroid cancer and MEN2 syndrome.
- A positive result can guide surgery and screening for relatives.
- Testing is arranged after genetic counselling.
- Most thyroid cancers and thyroid conditions are not inherited in a simple pattern.
When it is considered
Genetic testing is offered when medullary thyroid cancer is diagnosed, when there is a family history of medullary cancer or MEN2, and in some children with congenital hypothyroidism or thyroid dysgenesis.
It may also be considered in families with multiple members affected by thyroid cancer or other endocrine tumours.
What testing involves
A blood or saliva sample is analysed for changes in specific genes — most commonly RET for medullary thyroid cancer. Results are interpreted alongside the clinical picture.
Genetic counselling before and after testing explains what a result means, its implications for relatives, and any limitations.
Implications for family
Some thyroid cancer syndromes are inherited in an autosomal dominant pattern, meaning each child of an affected parent has a chance of inheriting the change. Relatives can then be offered testing and, if positive, screening or preventive surgery.
This is why genetic counselling is an essential part of testing.
Limitations
A negative result does not always exclude an inherited cause, because testing may not cover every possible gene change. Variants of uncertain significance can also complicate interpretation.
Testing is therefore used selectively and with specialist input.
When to seek urgent medical help
- A family history of medullary thyroid cancer or MEN2.
- Multiple family members with thyroid cancer at a young age.
- A thyroid lump with high blood pressure or other endocrine tumours.
This guidance does not replace emergency services. If you are seriously unwell, seek urgent medical care immediately.
Frequently asked questions
Should everyone with thyroid cancer have genetic testing?
No — testing is targeted. It is most clearly indicated for medullary thyroid cancer and selected familial cases.
What is MEN2?
Multiple endocrine neoplasia type 2 is an inherited syndrome that can cause medullary thyroid cancer, adrenal tumours and parathyroid problems. RET testing is central to diagnosis.
Can testing affect my children?
If a hereditary change is found, relatives may be offered testing so that screening or preventive treatment can be arranged.
Is genetic testing confidential?
Results are medical information handled confidentially, though they may have implications for insurance in some countries. Genetic counselling covers this.
References & further reading
This page is based on established medical knowledge and guidelines from authoritative sources. Always consult a qualified clinician for personal medical advice.
Ready to discuss your thyroid health?
Book a specialist consultation — in person or by teleconsultation.